Altria Group, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Salvatore Mancuso
- Full Time Employees
- 5,900
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Address
- 6601 West Broad Street Richmond VA United States of America 23230
- IPO Date
- Jul 1, 1985
- CIK
- 0000764180
- Website
- altria.com
- Similar Companies
- Business
- Altria Group, Inc. holds a leading position in the U.S. tobacco industry as a holding company that, through its subsidiaries, manufactures and sells cigarettes, machine-made large cigars, pipe tobacco, moist smokeless tobacco products, oral nicotine pouches, and e-vapor products. Its core offerings include Marlboro and Parliament cigarettes from Philip Morris USA; Black & Mild cigars from John Middleton; Copenhagen, Skoal, and Red Seal moist smokeless tobacco from U.S. Smokeless Tobacco Company; on! and on! PLUS oral nicotine pouches from Helix Innovations; and NJOY ACE and NJOY DAILY e-vapor products from NJOY, the first to receive FDA market authorizations for both tobacco and menthol variants. The company also maintains a majority-owned joint venture with JT Group, Horizon Innovations, for heated tobacco stick products in the U.S., alongside equity investments in Anheuser-Busch InBev and Cronos Group. Founded in 1985 and headquartered in Richmond, Virginia, Altria operates primarily in the United States, targeting adult nicotine consumers aged 21 and older across smokeable products, oral tobacco, and smoke-free categories. In recent developments, Altria entered a non-binding memorandum of understanding with KT&G Corporation in 2025 to pursue long-term growth in international innovative smoke-free products, non-nicotine offerings, and operational efficiencies, including Altria's acquisition of a stake in Another Snus Factory Stockholm, producer of the LOOP nicotine pouch brand, to expand in Nordic and U.S. markets. The company launched on! PLUS oral nicotine pouches, contributing to profit gains in its oral tobacco segment amid competitive pricing pressures. Additionally, Altria expanded its share repurchase program to $2 billion through December 2026, raised its 60th consecutive dividend, and narrowed its 2025 adjusted diluted EPS guidance to $5.37-$5.45, reflecting 3.5%-5.0% growth over 2024.
Company News
2 Dividend Kings to Buy Now and 1 to Avoid Despite the Yield
PM vs. MO: The Smoke-Free Dividend Winner in This Tobacco Showdown
Own This Cigarette Stock Or Treasuries?
Envestnet Asset Management Inc. Buys 214,108 Shares of Altria Group, Inc. $MO
Don't Look Now: 4 S&P 500 Giants Pay 6% and Higher Dividends
US FDA plans move to speed up vape, pouch approvals, WSJ reports
These 6 High-Yield Dividends May Be Too Good to Be True
Sin Stock Investing: Finding Opportunities in Controversial Industries
Can Altria's on! Build Share as Nicotine Pouches Keep Growing?
Staples ETF Widens Gap Over Discretionary in 2026
If You Invest $150 Per Month in Altria Group Stock, Here's the Passive Dividend Income It Could Generate Over 10 Years
Altria (MO) Stock Dips While Market Gains: Key Facts
High-Yield Dividend Stocks Throw Off Serious Income. Where You Hold Them Matters
4 Tobacco Stocks Turning Huge Cash Flow Into High-Yield Dividends
The Dividend Kings Ranked By Quality Scores (September 2026)
Altria Stock Trades at a Discount: Should You Buy, Sell or Hold?
One of These Dividend Kings Pays Out More Than It Earns. Which Dividend Is Safer?
British American Tobacco vs Altria: Which High-Yield Dividend Stock Is the Better Buy
Is Trending Stock Altria Group, Inc. (MO) a Buy Now?
How a Roth IRA Can Keep Thousands More of Your High-Yield Dividend Income Compounding